hers compounded semaglutide safety Hims stock plunges as Lilly's Zepbound weight-loss drug shortage ends Hims & Hers announces access

Lillys weight-loss pill could get FDA approval next year, CEO says Zepbound vs

The protein helps with satiety, muscle support, and stabilizing blood sugar, which is especially important when your eating window is smaller on a GLP-1

The cause is still open

On December 22, 2025, the FDA approved Novo Nordisk's once-daily oral semaglutide (Wegovy pill, 25 mg) for chronic weight management and cardiovascular risk reduction (FDA / Novo Nordisk, 2025)

Effect of exendin (exenatide): GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model

[DOI] [PubMed] [Google Scholar] 109.Thondam S.K., Cross A., Cuthbertson D.J., Wilding J.P., Daousi C